US Broker Ratings

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a 20% Upside Potential in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector, is captivating investor attention with its robust product offerings in the medical instruments and supplies industry. With a..

Insulet Corporation (PODD) Stock Analysis: Exploring a 68.78% Potential Upside for Investors

Insulet Corporation (NASDAQ: PODD) stands at the forefront of the medical devices sector, focusing on innovative insulin delivery systems. As the healthcare industry continues to evolve, Insulet’s cutting-edge technology and..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a Potential 58.42% Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP), a pioneering force in the medical devices sector, has captured investor attention with its innovative approach to treating obstructive sleep apnea (OSA). With a..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Unpacking an 88.96% Potential Upside Amidst Revenue Challenges

Atrium Therapeutics, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector with its focus on RNA therapeutics aimed at treating cardiomyopathies. Despite facing significant revenue challenges, the company’s innovative..

Rhythm Pharmaceuticals (RYTM): Analyst Ratings Signal 81% Potential Upside for Biotechnology Innovator

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a dynamic player in the biotechnology sector, presents an intriguing opportunity for investors eyeing significant growth potential. The Boston-based company, specializing in treatments for rare..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 30.92% Potential Upside for Investors

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a dynamic player in the biotechnology sector, has captured the attention of investors with its focus on novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). Headquartered..

ResMed Inc. (RMD) Stock Analysis: Exploring a 34.65% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a titan in the healthcare sector, specializes in developing and marketing innovative medical devices and cloud-based software applications aimed at managing respiratory disorders. With a market..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 38.96% Potential Upside

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is navigating turbulent waters with an intriguing potential upside for investors. Trading at $15.97, the stock is near its..

Nuvalent, Inc. (NUVL) Stock Analysis: A Potential 48.91% Upside in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL), a dynamic player in the biotechnology sector, is currently making waves in the healthcare industry with its innovative approach to cancer treatment. Headquartered in Cambridge, Massachusetts,..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Promising 62.85% Upside Potential for Investors

TransMedics Group, Inc. (NASDAQ: TMDX) presents an intriguing opportunity for investors in the medical technology sector, particularly those focused on innovative healthcare solutions. The company, headquartered in Andover, Massachusetts, is..

Oscar Health, Inc. (OSCR)

⚠️ No article content returned.

..

Stryker Corporation (SYK) Stock Analysis: Exploring a 29.82% Potential Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK), a stalwart in the healthcare sector, is capturing the attention of investors with its promising potential upside of 29.82%. As a leader in the medical devices..

Vaxcyte, Inc. (PCVX) Investor Outlook: Exploring a 105% Potential Upside in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX), a burgeoning name in the biotechnology sector, is capturing investor attention with its innovative approach to vaccine development and impressive potential upside. As a clinical-stage company..

Bio-Techne Corp (TECH) Stock Analysis: Unpacking a 47% Potential Upside for Investors

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology sector, is garnering attention with a potential upside of 47.02%, as suggested by the latest analyst target prices. With its..

argenx SE (ARGX) Stock Analysis: Significant Upside Potential and Robust Buy Ratings in the Biotech Sector

argenx SE (ARGX), a Netherlands-based biotechnology company, is commanding investor attention with its promising pipeline and substantial growth potential. Situated in the healthcare sector, argenx is renowned for its innovative..

TG Therapeutics, Inc. (TGTX)

⚠️ No article content returned.

..

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

RadNet, Inc. (RDNT) Investor Outlook: Analysts See a 64.51% Upside Potential

RadNet, Inc. (NASDAQ: RDNT) is positioning itself as a pivotal player in the healthcare sector, specifically within diagnostics and research. With a significant market capitalization of $4.36 billion, RadNet offers..

BrightSpring Health Services, I (BTSG) Stock Analysis: Exploring a 24.26% Upside Potential in the Healthcare Sector

BrightSpring Health Services, Inc. (NASDAQ: BTSG) is gaining attention in the healthcare sector, particularly in the health information services industry, with a promising potential upside of 24.26% as indicated by..

UnitedHealth Group (UNH) Stock Analysis: 38.57% Upside Potential Amid Strong Revenue Growth

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, continues to be a focal point for investors seeking stability and growth. With a market capitalization of $235.11 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds